Company Description

Cerevia Neurosciences is developing Ladybug™, a first-in-class AI-enabled, mobile fMRI-guided neuromodulation platform designed to restore impaired brain circuitry and cognitive functioning in patients with dementia. Addressing one of healthcare’s largest unmet needs, Cerevia delivers non-invasive, image-guided neuromodulation directly to patients where they live and receive care — including assisted living and memory-care facilities.